Posted May 11, 2020
When President Trump brought up hydroxychloroquine as a promising potential treatment for COVID-19, a huge upsurge of negative political publicity followed from it. It was strange stuff, because up until then, the treatment, which had been safely used to treat malaria, lupus, and arthritis, had been seeing promising results for COVID-19, too. Yet the condemnations from all sides poured for weeks. It wasn’t just the political establishment blasting it; it seemed to be the medical establishment, too. That raises questions as to whether financial interests might be involved here. Read more.